Patients with Parkinson’s disease (PD) present a variety of oral disease that can be worsened by xerostomia and sialorrhea. The patients’ physical limitations, for example rigidity and tremor, add to the difficulty of oral care by the general dental surgeon. The objective of the present review was to organize a list of evidence-based recommendations for the oral care of patients with PD.
Methods
A systematic review of the literature was carried out by specialists who selected the relevant papers and created a list of recommendations based upon the literature.
Results
Fourteen papers (data reported in 16 articles) were included in this review. Patients with PD had reduced quality of oral health and hygiene, and high prevalence of gingival recession, periodontal disease, dental calculus, tooth decay, tooth mobility and loss, drooling, xerostomia, dysphagia and temporomandibular disorders. Most studies offered class IV evidence, while one paper had class II evidence.
Conclusion
Patients with PD present poor oral health with conditions that are mostly preventable.
Patients with Parkinson’s disease (PD) present a variety of oral disease that can be worsened by xerostomia and sialorrhea.
A systematic review of the literature was carried out and a list of recommendations has been created.
Patients with PD present poor oral health with conditions that are mostly preventable.
Routine consultations with dental surgeons may improve the quality of life of patients with PD.
Digital Features
This article is published with digital features, including a summary slide, to facilitate understanding of the article. To view digital features for this article go to https://doi.org/10.6084/m9.figshare.14096261.
Anzeige
Introduction
Parkinson’s Disease (PD) is one of the most frequent neurodegenerative diseases, characterized by motor, autonomic, cognitive and behavioral symptoms [1]. Patients with PD will live with this condition from its onset until death, undergoing a variety of pharmacological and/or non-pharmacological treatments. At disease onset, often concerned with mobility limitations, the patient and the physician will focus on this aspect of the disease. Subsequently, cognitive and behavioral symptoms may add to the disease burden, while superimposed autonomic dysfunction makes PD management particularly challenging [2]. Faced with these myriad disabling symptoms, it is not unexpected that oral health may become a secondary aspect of the patients’ lives.
The interdisciplinary approach to patients with PD is highly recommended, but it is not common to have a dentist in the group [3]. Oral care of these patients is often neglected by the patients and their caregivers and physicians [4]. Some diseases reported in patients with PD include increased prevalence of caries and periodontal disease, sialorrhea and drooling, xerostomia, orofacial pain, bruxism and taste impairment [4]. The physiopathology of oral disorders in patients with PD is complex and is not fully understood. Drooling, for example, can be caused by dopamine-induced increased speed of salivary excretion, increased salivary flow rate swallowing dysfunction, hypomimia, lingual bradykinesia and abnormal flexed posture in a patient with reduced salivary production [5]. Although the association between xerostomia and drooling may seem paradoxical, in PD these two conditions may often occur together [5]. In addition, chronic oral inflammation by Porphyromonas gingivalis, a keystone pathogen in periodontitis, causes microbial dysbiosis typical of the neuroinflammation [6]. Periodontal disease has been considered a feature of PD due to poor motor and cognitive control, leading to poor oral health maintenance [7, 8]. However, the association between the two conditions may be two-sided. Chronic neuroinflammation is consistently associated with the pathophysiology of PD and is one of the contributing factors for neurodegeneration [8]. P. gingivalis may be associated with the development of PD and may be more frequent in patients with periodontal disease [7].
The objective of the present study was to review different aspects of oral health in PD and to establish evidence-based recommendations for the prevention and treatment of oral cavity diseases.
Methods
Eligibility Criteria for Including Studies
Clinical trials and observational studies assessing different aspects of oral health among patients with PD were included in this review. These involved associations between different aspects of PD and oral cavity diseases, along with any type of treatment or preventive strategies. Case reports, reviews, guidelines and experimental studies were excluded. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
Anzeige
Search Strategies for Identifying Studies
A comprehensive and sensitive search was conducted first on 24 March 2020 and then updated on 23 November 2020, in the following electronic databases: MEDLINE (via PubMed), Embase (via Elsevier), Cochrane Central Register of Controlled Trials (CENTRAL), Latin American & Caribbean Health Sciences Literature (LILACS) (via Biblioteca Virtual em Saúde, BVS) and Brazilian Bibliography of Odontology (BBO) (via BVS). We also hand-searched the reference lists of relevant studies to identify any potentially eligible study. The full search strategies are presented in Supplementary File 1. There were no language or date restrictions.
Selection of Studies and Data Extraction
Two authors independently reviewed the title and abstracts recovered through the search using the Rayyan platform [3]. References identified as “potentially eligible” were analyzed in full text. Any disagreement was resolved by a third reviewer.
Data extraction from the studies included was performed by four independent reviewers using a pre-established data extraction form. The data gathered comprised the main characteristics of the studies included (study design, sample size, participant characteristics, intervention and comparator groups, outcomes assessed, follow-up and results). Any disagreement was resolved by two other review authors.
Data Synthesis
The results from the studies included were presented narratively in accordance with the hierarchy of evidence levels [4].
Results
Through the search strategies, a total of 121 references were retrieved. After removed 17 duplicates, 104 were screened using their titles and abstracts, and out of these, 41 potentially eligible references were analyzed in full text. Twenty-two studies did not meet the inclusion criteria and were excluded (reviews and case reports). Two other studies were excluded because they dealt with oral-related risk factors associated with the development of PD in previously healthy individuals. One study was excluded because it only discussed the reduction in the risk of developing PD when an individual underwent dental scaling [5]. This study compared two populations: 4765 adults with PD and 19,060 age-matched individuals without PD. Another study [6] investigated data from 20,175 individuals who were free from PD in 1973 and 1974, regarding the evolution of their health up to 2012. Among men, use of tobacco was associated with a lower risk of developing PD, but their number of teeth and the presence of plaque were not associated with having PD after 28 years of follow-up.
Thus, 14 studies (reported in 16 papers) were included in this review [7‐22]. Figure 1 shows the study selection process. Table 1 shows a summary of the data retrieved from the 16 articles that were included in the systematic review, along with the level of evidence for each of them. In summary, the studies pointed out that patients with PD had reduced quality of oral health and hygiene. Presence of PD was associated with gingival recession, periodontal disease, dental calculus, tooth decay, tooth mobility and loss, drooling, xerostomia, dysphagia and temporomandibular disorders. Except for one study with class II evidence [7], all the papers had class IV evidence.
Fig. 1
Flowchart of article selection for the systematic review
Table 1
Summary of the studies included in the systematic review
Patients with PD had poorer oral health (papilla bleeding index), gingival recession and tooth mobility, lower frequency of teeth brushing, longer time since the last dentist visit and reduced salivary flow
Dental implants had 82% success rate and improved both oral and general QoL among patients with SD
RCT randomized clinical trial, n number of participants, PD Parkinson's disease, G group, DMFT decayed, missing and filled teeth, CPI Community Periodontal Index, PAL periodontal attachment loss, TMD temporomandibular disorder, RDC/TMD Research Diagnostic Criteria for Temporomandibular Disorders, PID periodontal inflammatory disease, OHRQoL oral health-related quality of life, VPI visible plaque index, GOHAI General Oral Health Assessment Index, BMS burning mouth syndrome, QoL quality of life
×
Discussion
There is no question that oral health is important for everyone. Although oral diseases are largely preventable, they are among the most prevalent diseases globally, thus creating a public health problem [23].
Despite the relatively low level of evidence in studies on oral health among patients with PD, the data retrieved for this systematic review allowed us to create a set of simple guidelines. We thus created a list of practical, evidence-based recommendations for all neurologists and dentists who treat patients with PD.
Anzeige
General Dental Care
o
During neurological consultations, the physician needs to introduce the issue of visits to a dentist.
p
Should the patient not have regular dental appointments, the neurologist should refer this individual to an oral health care center.
q
Teeth brushing needs to be done regularly and should be performed alternating the right and the left hands, since rigidity and tremor may be more disabling in one limb as PD progresses. Therefore, the patient should learn to use either hand for oral hygiene.
r
Individualized instructions regarding oral hygiene, together with chewing and lip exercises, can improve oral health in PD cases [7].
Salivation
o
PD is associated with hyposalivation or xerostomia (autonomic and anticholinergic drugs), drooling (motor or dysphagia) and halitosis. [11‐13, 16]. The neurologist and the dentist should assess these conditions and establish the best possible approach to control them.
p
Low salivary flow can be relieved through artificial saliva spray [24].
q
Botulinum toxin applied to the parotid and submandibular glands can relieve drooling [25]. However, this procedure may increase xerostomia, and the risk/benefit ratio must be assessed carefully (Fuster Torres et al. [26]).
r
Photodynamic therapy on the tongue surface may be a good option for halitosis [27].
Tooth Decay and Loss
o
Patients with PD have a higher frequency of untreated caries [19, 20]. This can be corrected through regular dental appointments.
p
Tooth loss can be successfully corrected through osseointegrated implants, as shown in nine patients with PD and tooth loss in an open, uncontrolled study [22]. Partial and complete prostheses have also been presented as an alternative to tooth loss [14, 15, 28]. However, it needs to be kept in mind that placing dentures and keeping them functional may be a burden for patients with tremor, rigidity, xerostomia and drooling. In addition, denture stomatitis and inflammatory fibrous hyperplasia have been reported in patients with PD using dentures [8]. Therefore, whenever possible, osseointegrated implants are recommended.
Periodontal Disease
o
PD is associated with gingival recession and bleeding, plaques, dental calculus and tooth mobility [8, 18‐20]. Improved hygiene may ultimately lead to lower rates of periodontal disease and, consequently, less tooth loss. Regular visits to a periodontist should be encouraged.
Anzeige
Temporomandibular Disorder (TMD)
o
Patients with PD showed a higher prevalence of TMD, particularly women [9, 21]. While around 20% of patients with PD show signs and symptoms of TMD, the elderly population generally has a 12% prevalence of temporomandibular dysfunction [29]. Less than 4% of elderly subjects have severe TMD [30].
p
Untreated TMD may add to the burden of PD, by generating greater pain and orofacial dysfunction. TMD needs to be investigated and treated.
Burning Mouth Syndrome (BMS)
o
Although the prevalence of BMS is not higher than 4% among patients with PD, this condition has been correlated with poor oral conditions [17]. Therefore, to avoid adding a burden of BMS to individuals already presenting with disability, good oral health needs to be maintained among patients with PD.
Conclusions
Patients with PD have a variety of oral diseases that needs to be prevented, diagnosed and treated. The present paper provides a list of evidence-based recommendations for neurologists and dentists caring for these patients.
Acknowledgements
Funding
No funding or sponsorship was received for this study or publication of this article.
Anzeige
Authorship
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Disclosures
The authors Ana Luiza Cabrera Martimbianco, Fabio Cesar Prosdocimi, Camillo Anauate-Netto, Elaine Marcílio dos Santos, Gustavo Duarte Mendes and Yara Dadalti Fragoso have no conflicts of interest to declare. Yara Dadalti Fragoso is a member of the journal’s Editorial Board.
Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
Data Availability
Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Nach der Thrombektomie kleinere Fragmente über eine intraarterielle Lyse auflösen – dies könnte die Schlaganfalltherapie verbessern. Zwei aktuelle Studien ergeben für die periprozedurale Lyse jedoch keine großen Vorteile. Die Frage, wie viel sie nützt, bleibt weiter offen.
Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.
In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?
Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.
